Skip to main content
NEXALIS THERAPEUTICS LTD logo

NEXALIS THERAPEUTICS LTD — Investor Relations & Filings

Ticker · NX1 ISIN · AU0000456733 ASX Professional, scientific and technical activities
Open in API
Filings indexed 509 across all filing types
Latest filing 2021-07-26 Director's Dealing
Country AU Australia
Listing ASX NX1

About NEXALIS THERAPEUTICS LTD

https://nexalistherapeutics.com/

Nexalis Therapeutics Ltd focuses on the discovery and development of innovative small molecule therapies for the treatment of chronic inflammatory and autoimmune diseases. The company utilizes a proprietary drug discovery platform to target specific biological pathways, including the NLRP3 inflammasome, which is implicated in the progression of various systemic and neurodegenerative conditions. By developing highly selective and potent modulators, the organization aims to address significant unmet medical needs in patient populations suffering from debilitating inflammatory disorders. Research and development efforts are centered on translating complex biological insights into clinical-stage therapeutic candidates designed to improve patient outcomes and quality of life through precision targeting of immune system dysregulation.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice 2 pages 211.4KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities, including the number of shares held before and after the change, the nature of the change (on-market share purchases), and other related information. This is a report of personal share transactions by a company director, which fits the definition of 'Director's Dealing'. The document length is 3315 characters, which is consistent with a detailed notice rather than a brief announcement or a full report. Therefore, the correct classification is DIRS (Director's Dealing).
2021-07-26 English
Director Appointment/Resignation 1 page 137.1KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement regarding the appointment of a new Non-Executive Director and Chairman, Sean Williams, and the resignation of a current director, Rodney Hannington. It includes biographical details of the new appointee and mentions the withdrawal of a resolution related to the re-election of the resigning director at the upcoming AGM. There is no financial data, no report attached or referenced, and the content focuses solely on changes in the company's board of directors. Therefore, this document fits the category of Board/Management Information (MANG). The document length is short and it is clearly an announcement of management changes, not a report or presentation.
2021-07-26 English
Final Director's Interest Notice 2 pages 147.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including unlisted options and agreements to issue options. The content focuses on the personal share transactions and interests of a director who has ceased to be a director. There are no financial statements, earnings data, or management discussion. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades). The document length is short and specific to director interests, confirming the classification as DIRS.
2021-07-25 English
Final Director's Interest Notice 2 pages 145.7KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the cessation of a director and the director's interests in securities and contracts. This is a report of personal share transactions and interests by a company director, which fits the definition of Director's Dealing filings. The document length is short and focused solely on director interests, not broader financial or management information.
2021-07-25 English
Initial Director's Interest Notice 2 pages 147.0KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including shares held directly and indirectly, and notes the date of appointment of the director. The content is focused on disclosure of personal share transactions or holdings by a company director. There is no financial performance data, no report or announcement of financial results, no governance structure details beyond director interests, and no mention of meetings or votes. The document fits the definition of 'Director's Dealing' which involves reporting personal share transactions or holdings by company directors and executives (insider trades). The document length is short and specific to director interests, confirming classification as DIRS.
2021-07-25 English
New Board appointments - Dr Andrew Saich and Darryl Davies 3 pages 164.1KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated 20th July 2021 regarding the appointment of two new non-executive directors to the board of Lifespot Health Ltd, as well as the resignation of two existing directors. It provides detailed biographical information about the new appointees and thanks the departing directors. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no reference to shareholder votes or capital changes. The content focuses solely on changes in the company's board of directors. Therefore, the document fits the category of Board/Management Information (MANG). The document length (6828 characters) supports that it is a full announcement rather than a brief notice or report publication announcement.
2021-07-19 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.